People: AtriCure Inc (ATRC.OQ)
ATRC.OQ on NASDAQ Stock Exchange Global Market
9.80USD
1 Aug 2013
9.80USD
1 Aug 2013
Price Change (% chg)
$0.14 (+1.45%)
$0.14 (+1.45%)
Prev Close
$9.66
$9.66
Open
$9.69
$9.69
Day's High
$9.90
$9.90
Day's Low
$9.69
$9.69
Volume
21,398
21,398
Avg. Vol
24,141
24,141
52-wk High
$10.00
$10.00
52-wk Low
$5.90
$5.90
Summary
| Name | Age | Since | Current Position |
|---|---|---|---|
Richard Johnston |
78 | 2005 | Independent Chairman of the Board |
Michael Carrel |
42 | 2012 | President, Chief Executive Officer, Director |
M. Andrew Wade |
38 | 2013 | Chief Financial Officer, Vice President |
Douglas Seith |
47 | 2013 | Senior Vice President - Sales and Marketing |
Andrew Lux |
61 | 2013 | Senior Vice President - R&D, Operations and QA |
Patricia Kennedy |
52 | 2011 | Vice President, General Manager - International |
Michael Rogge |
2013 | Vice President - Marketing | |
Michael Hooven |
57 | 2007 | Director |
Mark Collar |
60 | 2008 | Independent Director |
Donald Harrison |
79 | 2000 | Independent Director |
Elizabeth Krell |
64 | 2006 | Independent Director |
Mark Lanning |
58 | 2006 | Independent Director |
Karen Robards |
63 | 2000 | Independent Director |
Robert White |
51 | 2013 | Independent Director |
Biographies
| Name | Description |
|---|---|
Richard Johnston |
Mr. Richard M. Johnston serves as an Independent Chairman of the Board of AtriCure Inc. He has served as one of directors since June 2002 and as Chairman of the Board since February 2005. From 2000 to 2010, Mr. Johnston served as a Managing Member of Camden Partners Holdings, LLC, a private equity firm, and he is now a Retired Member of that firm and provides certain consulting services to it. Mr. Johnston currently serves as a director of BioMedical Enterprises, Inc. During the last five years Mr. Johnston previously served as director of privately-held LipoScience Inc., Lombard Medical Technologies PLC, Medivance, Inc. and Webmedx, Inc., all Camden Partners’ portfolio companies of which Lombard Medical Technologies PLC is a publicly-held company in the United Kingdom. He also served as Chairman of privately-held Picis, Inc. as well as a director of Pet DRx Corporation, a publicly-held company. From 1961 to 2000, Mr. Johnston was employed by The Hillman Company, an investment holding company with diversified operations, where he served from 1970 to 2000 as Vice President, Investments and as a director. From 1979 to 2003, Mr. Johnston was Chairman of the Board of The Western Pennsylvania Hospital and its successors, The Western Pennsylvania Healthcare System and West Penn Allegheny Health System. Mr. Johnston received his B.S. from Washington and Lee University and his M.B.A. from The Wharton School, University of Pennsylvania. |
Michael Carrel |
Mr. Michael H. Carrel serves as President, Chief Executive Officer, Director of AtriCure Inc. Mr. Carrel served as President and Chief Executive Officer of Vital Images, a publicly-traded medical imaging software company from 2008 until 2012. Mr. Carrel originally joined Vital Images in January 2005 as Chief Operating Officer and Chief Financial Officer. During Mr. Carrel’s tenure at Vital Images, he led the company to a leadership position in the healthcare and medical software industry. Under Mr. Carrel’s leadership, the company grew revenue and profitability, increased global market share, expanded its presence to over 90 countries, and raised $100 million in equity financing. Prior to Vital Images, Mr. Carrel was President and CEO of Zamba Corporation, a publicly-traded technology company and Chief Financial Officer of NextNet Wireless, a privately-held provider of non-line-of-sight plug and play broadband wireless access systems, now part of Motorola. Mr. Carrel holds a B.S. in Accounting from Pennsylvania State University and an M.B.A. from the Wharton School at the University of Pennsylvania. |
M. Andrew Wade |
Mr. M. Andrew Wade, CPA, serves as Chief Financial Officer, Vice President of AtriCure Inc. Mr. Wade has worked in various financial positions since joining AtriCure in October 2007, including Manager of Financial Planning & Analysis and Director of Finance. Prior to joining AtriCure, Mr. Wade held various financial positions with Macy’s Inc. and Saks Inc. Mr. Wade started his career with Arthur Andersen LLP in the audit practice, serving clients in various industries. Mr. Wade received his B.S.B.A. in Accounting from Xavier University and his Master in Business Administration from the Owen School at Vanderbilt University and is a Certified Public Accountant. |
Douglas Seith |
Mr. Douglas J. Seith serves as Senior Vice President - Sales and Marketing of AtriCure Inc. Having previously served as Vice President, United States Sales since April 2011. Since joining AtriCure in 2004 as a Regional Sales Leader, Mr. Seith has held a variety of progressive sales and sales leadership positions, including Area Director roles. Mr. Seith has over 25 years of cardiology and general surgery sales and sales leadership experience. Prior to joining AtriCure, Mr. Seith held sales leadership and/or sales positions with A-Med/EmoblX, Inc., where he was the Vice President of Sales, Heartport, Inc., Scimed Life Systems, a division of Boston Scientific, Inc. and Automated Instruments (a division of Unites States Surgical Corporation). Mr. Seith received his B.A. from Ohio Wesleyan University. |
Andrew Lux |
Dr. Andrew L. Lux, Ph.D., serves as Senior Vice President - R&D, Operations and QA of AtriCure Inc. Dr. Lux previously served as Vice President and Chief Operating Officer from 2012 to 2013. Since 2010, Dr. Lux served as the Senior Vice President of Manufacturing and Operations for IntriMed Technologies, a start-up business focused on contract manufacturing of implantable medical devices. From 2008 to 2010, Dr. Lux was the Vice President of Research and Development, Operations and Service for WaterHealth International, Inc., a business focused on the water purification/disinfections markets. From 2006 to 2008, Dr. Lux was the General Manager for Medtronic, Inc.’s spinal division in Warsaw, Indiana, where he was responsible for the United States based manufacturing organization providing spinal implant and orthopedic instrumentation products. Prior to 2006, Dr. Lux served in a variety of executive capacities for medical device organizations including Baxter Healthcare, Inc., Medtronic, Inc. (Cardiac Surgery Division), Johnson & Johnson and General Electric Company. |
Patricia Kennedy |
Ms. Patricia J. Kennedy serves as Vice President, General Manager - International of AtriCure Inc. She has served as Vice President and General Manager, International since October 2011, having previously served as Vice President, International Sales from 2009 to 2011 and as Director of Market Development, Europe from 2008 to 2009. From 2001 through 2008, Ms. Kennedy held various executive level positions with Stereotaxis, Inc., a manufacturer and marketer of cardiology instrument controls systems to enhance the treatment of coronary artery disease and arrhythmias, including Worldwide Vice President, Clinical Services and Vice President Sales and Marketing, Europe. Prior thereto, Ms. Kennedy held various sales and marketing positions in the medical device industry, including positions with EP Medsystems, Inc. and EP Technologies, Inc., a division of Boston Scientific Corporation. Ms. Kennedy, who is a Registered Nurse, received her Bachelor of Science Degree in Marketing from the University of North Florida and an Associates of Science Degree in Technical Nursing from Florida Junior College. |
Michael Rogge |
Mr. Michael J. Rogge serves as Vice President - Marketing of AtriCure Inc. He has served as Senior Director of Marketing since July 2011. Mr. Rogge joined AtriCure in 2006 as Product Director and was promoted to Director of Marketing in 2007. Prior to joining AtriCure, Mr. Rogge held director level positions in marketing business development, and financial management at Ethicon Endo-Surgery, a Johnson & Johnson Company, Hill-Rom, and Baxter International. Mr. Rogge received his B.A. from Miami University and his Masters in Business Administration from Lake Forest Graduate School of Management with honors. |
Michael Hooven |
Mr. Michael D. Hooven serves as Director of AtriCure Inc. He is is one of company's founders and has served as a director since August 2002 and as a consultant during 2007 and 2009. From August 2002 through December 2006, Mr. Hooven served as Chief Technology Officer and from August 2002 through February 2005, he served as Chairman of the Board. From November 2000 to August 2002, he served as President and Chief Executive Officer. Mr. Hooven is currently President and Chief Executive Officer of Enable Medical Technologies, LLC, a start-up business focusing on opportunities in minimally invasive surgery. Since 1994 until its acquisition, Mr. Hooven served as Chairman of the Board, and has previously served as President and Chief Executive Officer of Enable Medical Corporation, a developer and manufacturer of surgical instruments that Mr. Hooven co-founded and that AtriCure acquired on August 10, 2005. Mr. Hooven is also a director of BioOhio, a non-profit organization which promotes the acceleration and growth of life science companies in Ohio, and Minimally Invasive Devices LLC, a privately-held medical device company that develops products that facilitate minimally invasive surgery. From 1986 to 1994, Mr. Hooven served as Director of New Product Development at Ethicon Endo-Surgery, Inc., a developer and manufacturer of minimally invasive surgical instruments. In addition, Mr. Hooven has also served in a variety of positions at Cordis Corporation and Siemens Medical of Siemens AG. Mr. Hooven received his B.S. and M.S. from the University of Michigan. |
Mark Collar |
Mr. Mark A. Collar serves as an Independent Director of AtriCure Inc. Mr. Collar retired in 2008 as an executive from the Procter and Gamble Company where his roles included President of the Global Pharmaceuticals and Personal Health business. Mr. Collar joined Procter and Gamble in 1975 as a sales representative and assumed roles of progressive responsibility within their Health and Personal Care, Beauty Care, New Business Development and Personal Health Care products divisions. Mr. Collar joined Procter and Gamble’s Pharmaceuticals division in 1994 and was named President of Global Pharmaceuticals in 2002. Mr. Collar is currently a venture partner at Triathlon Medical Ventures, a Midwest-based life science venture capital firm, and a director of First Financial Bancorp, a publicly-held bank holding company, in addition to several philanthropic and economic development roles. Mr. Collar received his B.S. from Northern Illinois University. |
Donald Harrison |
Dr. Donald C. Harrison, M.D., serves as an Independent Director of AtriCure Inc. Since 2004, Dr. Harrison has served as a Managing Partner of Charter Life Sciences, L.P., a venture capital investment firm. He is presently serving as a director of Sidis Technologies, Inc., a privately-held information technology services company, CoRepair, Inc., a privately-held heart failure company, Ischemia Care LLC, a privately-held company that performs genetic testing for stroke, and Minimally Invasive Devices LLC, a privately-held medical device company that develops products that facilitate minimally invasive surgery. From 1986 to 2003, Dr. Harrison was the Senior Vice President and Provost for Health Affairs at the University of Cincinnati. In this capacity, he served as the Chief Executive Officer of the Medical Center. Dr. Harrison has previously served as a director of various publicly-held companies, including Kendle International Inc., EnteroMedics, Inc., EP Technology, Inc., Novoste Corporation, InControl, Inc. and SciMed, Inc. From 2000 to 2003, Dr. Harrison served as a director of Enable Medical Corporation, a developer and manufacturer of surgical instruments that AtriCure acquired on August 10, 2005. From 1968 to 1986, Dr. Harrison served as co-director of the Falk Cardiovascular Research Center in Stanford, California, Professor of Medicine and William G. Irwin Professor of Cardiology at Stanford University School of Medicine and Chief of Cardiology at Stanford University Hospital. Dr. Harrison received his B.S. from Birmingham Southern College and his M.D. from the University of Alabama College of Medicine. |
Elizabeth Krell |
Dr. Elizabeth D. Krell, Ph.D., serves as an Independent Director of AtriCure Inc. Dr. Krell is currently a private consultant on matters pertaining to FDA-regulated products, as well as FDA policies and procedures. From 2003 to 2004, she served as the Executive Vice President for Technology and Regulatory Affairs at the Advanced Medical Technology Association (AdvaMed), the trade association for medical device manufacturers. From 1975 to 2001, she served in the FDA, starting as a bench researcher and ending in the FDA’s top science job as the Acting Senior Advisor for Science, advising the Commissioner and other top FDA officials on science and science management. Dr. Krell served from 1990 to 2001 as the Deputy Director for Science in the FDA’s Center for Devices and Radiological Health (CDRH). In this position, she provided executive leadership in the development of programs to assure the safety and effectiveness of medical devices and diagnostic products and the reduction of population exposure to radiation emitted from medical, industrial and consumer products. Previously, she directed CDRH’s science and engineering labs. Dr. Krell received her B.A. from S.U.N.Y. Binghamton and her Ph.D. from Georgetown University. |
Mark Lanning |
Mr. Mark R. Lanning, CPA., serves as an Independent Director of AtriCure Inc. Mr. Lanning currently serves as Vice President-Finance and Chief Financial Officer of Frisch’s Restaurants. Prior to joining Frisch’s, Mr. Lanning served as Vice President, Investor Relations and Treasurer of Hillenbrand, Inc. and Hillenbrand Industries, diversified leaders in the healthcare equipment, funeral services and material handling industries. Prior to joining Hillenbrand in 1988, Mr. Lanning spent twelve years in various accounting positions with Ernst & Whinney (now Ernst & Young). Mr. Lanning, a Certified Public Accountant, also has served as a member of the Council of the American Institute of CPAs and is a past Chairman of the Indiana CPA Society. Mr. Lanning received his B.S. in Accounting from Ball State University. |
Karen Robards |
Ms. Karen P. Robards serves as an Independent Director of AtriCure Inc. Since 1987, Ms. Robards has been a partner of Robards & Company, LLC, a financial advisory firm. From 1976 to 1987, Ms. Robards was an investment banker at Morgan Stanley where she headed its healthcare investment banking activities. Ms. Robards served from 1996 to 2005 as a director of Enable Medical Corporation, a developer and manufacturer of surgical instruments, which AtriCure acquired on August 10, 2005. From 2007 to 2010, Ms. Robards also served as a director of Care Investment Trust, a publicly-held real estate investment trust focusing on investment opportunities in the healthcare industry. Ms. Robards currently serves as Vice Chair of the Board and Chair of the Audit Committee of BlackRock Closed-End Funds. Ms. Robards is a founder and director of the Cooke Center for Learning & Development, a not-for-profit educational organization in New York City. Ms. Robards received her B.A. from Smith College and her M.B.A. from Harvard Business School. |
Robert White |
Mr. Robert S. White serves as an Independent Director of AtriCure Inc. Mr. White currently serves as President and CEO of TYRX, a privately-held company, which commercializes innovative, implantable combination drug and device products focused on infection control, including the AIGISRx® Antibacterial Envelope, designed to reduce surgical site infections associated with Cardiac Implantable Electronic Devices (CIEDs). Prior to joining TYRX, Mr. White held several positions with Medtronic, Inc. Mr. White served as President of Medtronic Kyphon following its $3.9 billion acquisition of the spinal treatment business. During his time with Medtronic, Mr. White also served as President of Physio Control and was responsible for commercial operations of the Cardiac Rhythm Disease Management business as Vice President of U.S. Sales and Global Marketing. Earlier in his career, Mr. White held positions with General Electric Company and Eli Lilly and Company among others. Mr. White holds a MBA from Cornell University and a BS in Aerospace Engineering from the University of Missouri-Rolla. |
Basic Compensation
| Name | Fiscal Year Total |
|---|---|
Richard Johnston |
-- |
Michael Carrel |
1,901,800 |
M. Andrew Wade |
791,919 |
Douglas Seith |
-- |
Andrew Lux |
1,283,100 |
Patricia Kennedy |
883,353 |
Michael Rogge |
-- |
Michael Hooven |
269,363 |
Mark Collar |
-- |
Donald Harrison |
-- |
Elizabeth Krell |
-- |
Mark Lanning |
-- |
Karen Robards |
-- |
Robert White |
-- |
As Of 30 Dec 2012
Options Compensation
| Name | Options | Value |
|---|---|---|
Richard Johnston |
0 | 0 |
Michael Carrel |
0 | 0 |
M. Andrew Wade |
0 | 0 |
Douglas Seith |
0 | 0 |
Andrew Lux |
0 | 0 |
Patricia Kennedy |
8,750 | 113,537 |
Michael Rogge |
0 | 0 |
Michael Hooven |
92,104 | 945,251 |
Mark Collar |
0 | 0 |
Donald Harrison |
0 | 0 |
Elizabeth Krell |
0 | 0 |
Mark Lanning |
0 | 0 |
Karen Robards |
0 | 0 |
Robert White |
0 | 0 |
| Name | Shares Traded | Price |
|---|---|---|
JOHNSTON RICHARD M |
2,212 | $10.00 |
JOHNSTON RICHARD M |
131 | $10.00 |
CARREL MICHAEL H |
1,500 | $6.07 |
SEITH DOUGLAS J |
1,500 | $6.07 |
WADE M ANDREW |
832 | $6.07 |
JOHNSTON RICHARD M |
27,705 | $8.96 |
JOHNSTON RICHARD M |
1,643 | $8.96 |
JOHNSTON RICHARD M |
2,383 | $9.03 |
JOHNSTON RICHARD M |
40,165 | $9.03 |
JOHNSTON RICHARD M |
2,971 | $8.92 |
JOHNSTON RICHARD M |
50,079 | $8.92 |
JOHNSTON RICHARD M |
23,139 | $9.01 |
JOHNSTON RICHARD M |
1,373 | $9.01 |
JOHNSTON RICHARD M |
608 | $9.01 |
JOHNSTON RICHARD M |
10,252 | $9.01 |
WADE M ANDREW |
149 | $9.05 |
SEITH DOUGLAS J |
661 | $9.05 |
WADE M ANDREW |
202 | $9.24 |
LUCKY JAMES L |
4,000 | $8.22 |
LUCKY JAMES L |
616 | $8.22 |
LUCKY JAMES L |
31,500 | $8.13 |
LUCKY JAMES L |
13,949 | $8.13 |
LUCKY JAMES L |
9,473 | $1.52 |
LUCKY JAMES L |
31,500 | $5.60 |
LUCKY JAMES L |
13,949 | $6.34 |

